Public Meeting Notice

Guidelines for the Use of Buprenorphine

Fourth Buprenorphine Treatment Guidelines Workgroup Meeting

Workgroup members will meet to continue drafting the Buprenorphine Treatment Guidelines required by Public Chapter 112 of 2017

This meeting will be held:
When: Monday, Sept. 18, 2017, 1 - 4 p.m. CST

Where: *Conference Room G on the 3rd Floor of the Tennessee Tower
Address: 312 Rosa L. Parks Ave.
Nashville, Tennessee

*A state-issued I.D. is required for entry.

How Can I Participate Without Attending In Person?
Call Conference Line: 615-741-7735 or 855-689-9053 and/or access the Adobe Connect link:

Please note:
*All Workgroup meetings are open to the general public; however, seating will be extremely limited and will be offered to the Workgroup and its staff first. The seating capacity for Conference Room G is 20 people, and the Workgroup and its staff consists of 18 individuals.)  Additionally, please be aware that discussion amongst the Workgroup and its staff will be given priority during Workgroup meetings so that the Workgroup can do their work. If you would like to participate, it is recommended that you do so by dialing one of the Conference Line #s and/or accessing the Adobe Connect link provided above.

Contact: Kurt Hippel, Office of Legislation, Rules & Privacy